PLIVA announces acquisition of US-based Sidmak
PLIVA d.d. ("PLIVA") announced today a definitive agreement with Sobel N.V. ("Sobel") to acquire all of the shares (100%) of Sobel Holdings Inc. ("Sobel Holdings"), a US company which owns the pharmaceutical company Sidmak Laboratories, Inc. ("Sidmak"), and its wholly-owned subsidiary, Odyssey Pharmaceuticals, Inc. ("Odyssey"), for a cash consideration of USD 152.9 million and assumption of bank debt of USD 59 million.
Zagreb, 11 June 2002
- PR_Sidmak_FFF.pdf (187,0 KB)